Company / Return on Assets (ROA)
Phio Pharmaceuticals Corp. Return on Assets (ROA) History
FY2012-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-56.6%
FY2020
5-year range
-219.5% / -56.6%
FY2016-FY2020
Trend
+38.2%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has fluctuated over the past 7 years, ranging from -219.5% in FY2017 to -0.6% in FY2013.
Based on SEC 10-K filings.
-56.6% in FY2020 with a 3-year CAGR of +162.9%.
Improved from -81.3% to -56.6% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +162.9pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2020, return on assets (roa) increased 38.2% year-over-year.
- Peak return on assets (roa) was recorded in FY2013.
- Lowest return on assets (roa) in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.94 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2020 | -56.6% | +38.2% |
| FY2019 | -91.5% | -12.6% |
| FY2018 | -81.3% | +63.0% |
| FY2017 | -219.5% | -187.6% |
| FY2016 | -76.3% | -12618.3% |
| FY2013 | -0.6% | +62.3% |
| FY2012 | -1.6% | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026